The Best "Model System" for Human (Coronary Arteries) Is Human

Journal of the American College of Cardiology

Volumn 54, Issue 13, 2009, Pages 1146-1148

  Braun, Oscar Ö ^a   Insel, Paul A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

adrenergic; alpha and beta; arteries; coronary disease; receptors

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DRUG MECHANISM; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING;

CORONARY ARTERY DISEASE; CORONARY VESSELS; HEART VENTRICLES; HUMANS; MODELS, CARDIOVASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, ADRENERGIC, BETA;

EID: 70049097052     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.019     Document Type: Editorial

References (16)

1. Jensen B.C., Swigart P.M., Laden M.-E., DeMarco T., Hoopes C., and Simpson P.C. The alpha-1D is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries. J Am Coll Cardiol 54 (2009) 1137-1145
2. Bristow M.R., Minobe W.A., Raynolds M.V., et al. Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 92 (1993) 2737-2745
3. Steinfath M., Chen Y.Y., Lavicky J., et al. Cardiac alpha 1-adrenoceptor densities in different mammalian species. Br J Pharmacol 107 (1992) 185-188
4. Brodde O.E., Bruck H., Leineweber K., and Seyfarth T. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96 (2001) 528-538
5. Rozec B., and Gauthier C. beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111 (2006) 652-673
6. Kirstein S.L., and Insel P.A. Autonomic nervous system pharmacogenomics: a progress report. Pharmacol Rev 56 (2004) 31-52
7. Brodde O.E. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses. Pharmacol Ther 117 (2008) 1-29
8. Lanzafame A.A., Turnbull L., Amiramahdi F., Arthur J.F., Huynh H., and Woodcock E.A. Inositol phospholipids localized to caveolae in rat heart are regulated by alpha1-adrenergic receptors and by ischemia-reperfusion. Am J Physiol Heart Circ Physiol 290 (2006) H2059-H2065
9. Wolff D.W., Dang H.K., Liu M.F., Jeffries W.B., and Scofield M.A. Distribution of alpha1-adrenergic receptor mRNA species in rat heart. J Cardiovasc Pharmacol 32 (1998) 117-122
10. Jensen B.C., Swigart P.M., Laden M.E., DeMarco T., Hoopes C., and Simpson P.C. Alpha-1-adrenergic receptor subtypes in human heart failure. J Cardiac Fail 14 (2008) S3
11. Moore-Morris T., Varrault A., Mangoni M.E., et al. Identification of potential pharmacological targets by analysis of the comprehensive G protein-coupled receptor repertoire in the four cardiac chambers. Mol Pharmacol 75 (2009) 1108-1116
12. Simpson P., McGrath A., and Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 51 (1982) 787-801
13. Woodcock E.A., Du X.J., Reichelt M.E., and Graham R.M. Cardiac alpha 1-adrenergic drive in pathological remodelling. Cardiovasc Res 77 (2008) 452-462
14. Galderisi M., and D'Errico A. Beta-blockers and coronary flow reserve: the importance of a vasodilatory action. Drugs 68 (2008) 579-590
15. Lorenz K., Schmitt J.P., Schmitteckert E.M., and Lohse M.J. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med 15 (2009) 75-83
16. Azzi M., Charest P.G., Angers S., et al. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A 100 (2003) 11406-11411